Matches in Wikidata for { <http://www.wikidata.org/entity/Q103811675> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q103811675 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 1ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q103811675 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q103811675 description "scientific article published on 01 December 2020" @default.
- Q103811675 description "wetenschappelijk artikel" @default.
- Q103811675 description "наукова стаття, опублікована 1 грудня 2020" @default.
- Q103811675 name "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 name "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 name "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 type Item @default.
- Q103811675 label "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 label "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 label "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 prefLabel "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 prefLabel "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 prefLabel "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 P1433 Q103811675-6B37C7C9-F7C1-4E6F-9AAB-DC1CE6A3E5F1 @default.
- Q103811675 P1476 Q103811675-2F77FF51-C73C-4BA0-B8EE-4EA2AC59A66A @default.
- Q103811675 P2093 Q103811675-2C8E412C-9914-4CC0-9535-F50114B452C4 @default.
- Q103811675 P2093 Q103811675-52604149-57BD-46A3-A32B-73643A9D576C @default.
- Q103811675 P2093 Q103811675-80F259E0-5DCE-466E-A52C-2F6A0A3AFB0C @default.
- Q103811675 P2093 Q103811675-8313756D-0448-43D4-AF76-62581FF6CF0B @default.
- Q103811675 P2093 Q103811675-85201D07-FC75-4821-A383-9043946022F7 @default.
- Q103811675 P2093 Q103811675-95C20B2A-D368-4A5B-A985-8B9ECEF86564 @default.
- Q103811675 P2093 Q103811675-B74B631D-B76C-409E-9858-85C4A8798254 @default.
- Q103811675 P2093 Q103811675-C513D8E7-D147-4452-9C76-F4BBA642E8B7 @default.
- Q103811675 P2093 Q103811675-CE3EF480-FA65-4ABD-8D13-FA5D41B683A1 @default.
- Q103811675 P2093 Q103811675-D3E82D35-7A90-4AC6-9F3E-2B09B04A20E2 @default.
- Q103811675 P304 Q103811675-2B4AF958-8C22-4226-9B49-8E7F12C9100D @default.
- Q103811675 P31 Q103811675-DAE07AF4-93BF-4295-AB02-32F81625ACC9 @default.
- Q103811675 P356 Q103811675-B3565B16-9E7B-4C28-982F-1DB719C0755F @default.
- Q103811675 P433 Q103811675-2D82CB1A-2469-4F5B-9D72-A87A7F40D035 @default.
- Q103811675 P478 Q103811675-660E3722-20A9-4858-822D-EF29E5088B59 @default.
- Q103811675 P50 Q103811675-EA9C7D60-E47B-4236-AC0E-B23BB11AFDA8 @default.
- Q103811675 P577 Q103811675-B878763C-1A33-4963-8B0D-3D15AA88A699 @default.
- Q103811675 P698 Q103811675-B8E21ACB-AEAA-455E-BA8C-7F365FB86200 @default.
- Q103811675 P921 Q103811675-06D13D2C-88B6-4289-B82C-B8561A8ECCF9 @default.
- Q103811675 P932 Q103811675-D662BDC1-BCF1-4AA6-A9B6-5EDFB050B188 @default.
- Q103811675 P356 JAMANETWORKOPEN.2020.27754 @default.
- Q103811675 P698 33258908 @default.
- Q103811675 P1433 Q63615743 @default.
- Q103811675 P1476 "Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis" @default.
- Q103811675 P2093 "Arul Nancy" @default.
- Q103811675 P2093 "Dina Nair" @default.
- Q103811675 P2093 "Kadar Moideen" @default.
- Q103811675 P2093 "Kannan Thiruvengadam" @default.
- Q103811675 P2093 "Nathella P Kumar" @default.
- Q103811675 P2093 "Shanmugam Sivakumar" @default.
- Q103811675 P2093 "Subash Babu" @default.
- Q103811675 P2093 "Syed Hissar" @default.
- Q103811675 P2093 "Vaithilingam V Banurekha" @default.
- Q103811675 P2093 "Vijay Viswanathan" @default.
- Q103811675 P304 "e2027754" @default.
- Q103811675 P31 Q13442814 @default.
- Q103811675 P356 "10.1001/JAMANETWORKOPEN.2020.27754" @default.
- Q103811675 P433 "12" @default.
- Q103811675 P478 "3" @default.
- Q103811675 P50 Q88374714 @default.
- Q103811675 P577 "2020-12-01T00:00:00Z" @default.
- Q103811675 P698 "33258908" @default.
- Q103811675 P921 Q13046587 @default.
- Q103811675 P932 "7709089" @default.